The Future of Creatinine Measurement Market


Posted June 6, 2022 by NeilR112

The diagnostic laboratories segment is expected to witness the highest growth over the forecast period as various market players
 
The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 377.2 Million in 2018, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches.



[210 Pages Report] The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 349.9 Million in 2017, at a CAGR of 8.4%. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.



This report segments the creatinine measurement market on the basis of type, type of sample, end user, product, and region. By type, the market is segmented into Jaffe’s kinetic method and enzymatic method. In 2018, the Jaffe’s kinetic method segment is estimated to account for the largest share of the creatinine measurement market, as it is the oldest and most conventional method for creatinine measurement in clinical samples.



Additionally, the widespread availability and cost-effectiveness of kits and reagents used in Jaffe’s kinetic method is another major factor responsible for the large share of this segment.



Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206847385



Based on type of sample, the market is segmented into blood/serum and urine samples. The blood sample segment accounted for the largest share of the creatinine measurement market in 2017 due to the increased accuracy and low risk of contamination. This segment is also expected to witness the highest growth over the forecast period, as it is the most preferred sample type for accurate measurement of creatinine levels.





Based on end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. In 2018, the hospitals segment is expected to account for the largest share of the creatinine measurement owing to established infrastructures with an advanced diagnostic assembly for better diagnostic results within shorter time spans.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MnM
Country United Kingdom
Categories Health , Medical , News
Tags health
Last Updated June 6, 2022